Diabetes I

Diabetes I

This is a self-grading exam. Answers are entered by clicking the button corresponding to your selection. The examination is scored by clicking 'Grade Test' at the bottom of the form. Correct answers are found through hyperlinks at the bottom of the page.



Question # 1 (Multiple Choice) Less likely to cause hepatotoxicity

    A) rosiglitazone (Avandia)
    B) troglitazone (Rezulin)
    C) both equally hepatotoxic

Question # 2 (Multiple Answer) Second generation sulfonylurea

    A) chlorpropamide (Diabinese)
    B) tolazamide (Tolinase)
    C) glimepiride (Amaryl)
    D) glyburide (Micronase, DiaBeta)

Question # 3 (Multiple Answer) Complications of insulin treatment:

    A) tachycardia
    B) tremor
    C) palpitations
    D) hunger
    E) mental confusion

Question # 4 (Multiple Answer) Biguanides: clinical uses & advantages:

    A) does not increase weight
    B) does not cause hypoglycemia
    C) used in patients with refractory obesity
    D) used in patients with insulin resistance

Question # 5 (Multiple Answer) oral hypoglycemics: categories

    A) sulfonylureas -- glipizide (Glucotrol)
    B) biguanides -- metformin (Glucophage)
    C) alpha glucosidase inhibitor -- actor boasts
    D) thiozolidinediones -- rosiglitazone (Avandia)

Question # 6 (Multiple Answer) Treatment of severe hypoglycemia (unconscious patient) --

    A) IV glucose infusion
    B) 1 mg glucagon

Question # 7 (Multiple Choice) Adverse effects associated with acarbose (Precose)

    A) hypoglycemia if used in combination with insulin or sulfonylureas
    B) flatulence
    C) both
    D) neither

Question # 8 (True/False) Diabetic retinopathy is the leading cause of blindness in United States:

    A) true
    B) false

Question # 9 (Multiple Choice) Glyburide (Micronase, DiaBeta) -- contraindicated in:

    A) hepatic impairment
    B) renal insufficiency
    C) both
    D) neither

Question # 10 (Multiple Answer) Troglitazone (Rezulin):

    A) withdrawn for use as monotherapy
    B) approved for use in insulin-resistant patients receiving insulin
    C) increases tissue insulin sensitivity
    D) may cause rare, but occasionally lethal liver dysfunction

Question # 11 (Multiple Answer) Presenting symptoms of IDDM:

    A) oligouria
    B) polydipsia
    C) polyphagia

Question # 12 (Multiple Answer) Characteristics of autonomic neuropathy associated with diabetes:

    A) syncope
    B) cardiopulmonary arrest
    C) orthostatic hypotension
    D) constipation or diarrhea
    E) esophageal dysfunction

Question # 13 (True/False) Renal disease is the leading cause of death and disability due to diabetes

    A) true
    B) false

Correct Answers

1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13






































Question # 1 (Multiple Choice) Less likely to cause hepatotoxicity

Answer: (A) rosiglitazone (Avandia)

BACK







































Question # 2 (Multiple Answer) Second generation sulfonylurea

(C) glimepiride (Amaryl)

(D) glyburide (Micronase, DiaBeta)

BACK







































Question # 3 (Multiple Answer) Complications of insulin treatment:

(A) tachycardia

(B) tremor

(C) palpitations

(D) hunger

(E) mental confusion

secondary to hypoglycemia BACK







































Question # 4 (Multiple Answer) Biguanides: clinical uses & advantages:

(A) does not increase weight

(B) does not cause hypoglycemia

(C) used in patients with refractory obesity

(D) used in patients with insulin resistance

BACK







































Question # 5 (Multiple Answer) oral hypoglycemics: categories

(A) sulfonylureas -- glipizide (Glucotrol)

(B) biguanides -- metformin (Glucophage)

(C) alpha glucosidase inhibitor -- actor boasts

(D) thiozolidinediones -- rosiglitazone (Avandia)

BACK







































Question # 6 (Multiple Answer) Treatment of severe hypoglycemia (unconscious patient) --

(A) IV glucose infusion

(B) 1 mg glucagon

BACK







































Question # 7 (Multiple Choice) Adverse effects associated with acarbose (Precose)

Answer: (C) both

BACK







































Question # 8 (True/False) Diabetic retinopathy is the leading cause of blindness in United States:

Answer: True

BACK







































Question # 9 (Multiple Choice) Glyburide (Micronase, DiaBeta) -- contraindicated in:

Answer: (C) both

BACK







































Question # 10 (Multiple Answer) Troglitazone (Rezulin):

(A) withdrawn for use as monotherapy

(B) approved for use in insulin-resistant patients receiving insulin

(C) increases tissue insulin sensitivity

(D) may cause rare, but occasionally lethal liver dysfunction

BACK







































Question # 11 (Multiple Answer) Presenting symptoms of IDDM:

(B) polydipsia

(C) polyphagia

polyuria BACK







































Question # 12 (Multiple Answer) Characteristics of autonomic neuropathy associated with diabetes:

(A) syncope

(B) cardiopulmonary arrest

(C) orthostatic hypotension

(D) constipation or diarrhea

(E) esophageal dysfunction

BACK







































Question # 13 (True/False) Renal disease is the leading cause of death and disability due to diabetes

Answer: True

BACK